The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells
Open accessAbstract
The adoptive transfer of regulatory T cells (Tregs) offers a promising strategy to combat pathologies that are characterized by aberrant immune activation, including graft rejection and autoinflammatory diseases. Expression of a chimeric antigen receptor (CAR) gene in Tregs redirects them to the site of autoimmune activity, thereby increasing their suppressive efficiency while avoiding systemic immunosuppression. Since carcinoembryonic antigen (CEA) has been shown to be overexpressed in both human colitis and colorectal cancer, we treated CEA-transgenic mice that were induced to develop colitis with CEA-specific CAR Tregs. Two disease models were employed: T-cell-transfer colitis as well as the azoxymethane-dextran sodium sulfate model for colitis-associated colorectal cancer. Systemically administered CEA-specific (but not control) CAR Tregs accumulated in the colons of diseased mice. In both model systems, CEA-specific CAR Tregs suppressed the severity of colitis compared to control Tregs. Moreover, in the azoxymethane-dextran sodium sulfate model, CEA-specific CAR Tregs significantly decreased the subsequent colorectal tumor burden. Our data demonstrate that CEA-specific CAR Tregs exhibit a promising potential in ameliorating ulcerative colitis and in hindering colorectal cancer development. Collectively, this study provides a proof of concept for the therapeutic potential of CAR Tregs in colitis patients as well as in other autoimmune inflammatory disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256
Brentjens, R. J., Davila, M. L., Riviere, I., Park, J., Wang, X., Cowell, L. G., Bartido, S., Stefanski, J., Taylor, C., Olszewska, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005930 · Cited by 2,063
Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.017 · Cited by 1,586
CD4+CD25+ Regulatory Lymphocytes Induce Regression of Intestinal Tumors in ApcMin/+ Mice
Erdman, S. E., Sohn, J. J., Rao, V. P., Nambiar, P. R., Ge, Z., Fox, J. G., & Schauer, D. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3104 · Cited by 211
Research works printed but not linked: 44
- Loftus, 2004, Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences, Gastroenterology, 126, 1504, 10.1053/j.gastro.2004.01.063 · DOI · Paper page
- Eaden, 2001, The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut, 48, 526, 10.1136/gut.48.4.526 · DOI · Paper page
- Seibold, 1998, pANCA represents a cross-reactivity to enteric bacterial antigens, J Clin Immunol, 18, 153, 10.1023/A:1023203118100 · DOI
- Ohkura, 2013, Development and maintenance of regulatory T cells, Immunity, 38, 414, 10.1016/j.immuni.2013.03.002 · DOI · Paper page
- Izcue, 2009, Regulatory lymphocytes and intestinal inflammation, Annu Rev Immunol, 27, 313, 10.1146/annurev.immunol.021908.132657 · DOI · Paper page
- Ochs, 2007, IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity, Immunol Res, 38, 112, 10.1007/s12026-007-0022-2 · DOI · Paper page
- Collison, 2007, The inhibitory cytokine IL-35 contributes to regulatory T-cell function, Nature, 450, 566, 10.1038/nature06306 · DOI · Paper page
- Tarbell, 2007, Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice, J Exp Med, 204, 191, 10.1084/jem.20061631 · DOI · Paper page
- Stephens, 2009, Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg, Eur J Immunol, 39, 1108, 10.1002/eji.200839073 · DOI · Paper page
- Wright, 2009, Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis, Proc Natl Acad Sci USA, 106, 19078, 10.1073/pnas.0907396106 · DOI · Paper page
- Elinav, 2008, Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice, Gastroenterology, 134, 2014, 10.1053/j.gastro.2008.02.060 · DOI · Paper page
- Elinav, 2009, Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor, Gastroenterology, 136, 1721, 10.1053/j.gastro.2009.01.049 · DOI · Paper page
- Gross, 1989, Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity, Proc Natl Acad Sci USA, 86, 10024, 10.1073/pnas.86.24.10024 · DOI · Paper page
- Kochenderfer, 2012, B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells, Blood, 119, 2709, 10.1182/blood-2011-10-384388 · DOI · Paper page
- Louis, 2011, Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma, Blood, 118, 6050, 10.1182/blood-2011-05-354449 · DOI · Paper page
- Smithson, 1996, Heterogeneous expression of carcinoembryonic antigen in the normal colon and upregulation in active ulcerative colitis, J Pathol, 180, 146, 10.1002/(SICI)1096-9896(199610)180:2<146::AID-PATH643>3.0.CO;2-E · doi:10.1002/(sici)1096-9896(199610)180:2<146::aid-path643>3.0.co;2-e
- Chmielewski, 2012, T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in mice, Gastroenterology, 143, 1095, 10.1053/j.gastro.2012.06.037 · DOI
- Chan, 2004, Novel mouse model for carcinoembryonic antigen-based therapy, Mol Ther, 9, 775, 10.1016/j.ymthe.2004.03.009 · DOI
- Tanaka, 2003, A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate, Cancer Sci, 94, 965, 10.1111/j.1349-7006.2003.tb01386.x · DOI · Paper page
- Berg, 1996, Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses, J Clin Invest, 98, 1010, 10.1172/JCI118861 · DOI · Paper page
- Liu, 2003, CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4, J Immunol, 171, 5012, 10.4049/jimmunol.171.10.5012 · DOI · Paper page
- Singh, 2001, Control of intestinal inflammation by regulatory T cells, Immunol Rev, 182, 190, 10.1034/j.1600-065X.2001.1820115.x · DOI · Paper page
- Parkhurst, 2011, T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis, Mol Ther, 19, 620, 10.1038/mt.2010.272 · DOI · Paper page
- Zhao, 2009, A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity, J Immunol, 183, 5563, 10.4049/jimmunol.0900447 · DOI · Paper page
- Dieleman, 1998, Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines, Clin Exp Immunol, 114, 385, 10.1046/j.1365-2249.1998.00728.x · DOI · Paper page
- Dieleman, 1994, Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice, Gastroenterology, 107, 1643, 10.1016/0016-5085(94)90803-6 · DOI · Paper page
- Maloy, 2005, Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells, Immunol Lett, 97, 189, 10.1016/j.imlet.2005.01.004 · DOI
- Gallimore, 2008, Regulatory T cells and tumour immunity - observations in mice and men, Immunology, 123, 157, 10.1111/j.1365-2567.2007.02748.x · DOI
- Erdman, 2003, CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice, Am J Pathol, 162, 691, 10.1016/S0002-9440(10)63863-1 · DOI · Paper page
- Fearon, 1990, A genetic model for colorectal tumorigenesis, Cell, 61, 759, 10.1016/0092-8674(90)90186-I · DOI · Paper page
- Lim, 2005, Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells, J Immunol, 175, 4180, 10.4049/jimmunol.175.7.4180 · DOI · Paper page
- Fallarino, 2003, Modulation of tryptophan catabolism by regulatory T cells, Nat Immunol, 4, 1206, 10.1038/ni1003 · DOI · Paper page
- Tiemessen, 2007, CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages, Proc Natl Acad Sci USA, 104, 19446, 10.1073/pnas.0706832104 · DOI · Paper page
- Thornton, 2000, Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific, J Immunol, 164, 183, 10.4049/jimmunol.164.1.183 · DOI · Paper page
- Andersson, 2008, CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner, J Exp Med, 205, 1975, 10.1084/jem.20080308 · DOI · Paper page
- Nadig, 2010, In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells, Nat Med, 16, 809, 10.1038/nm.2154 · DOI · Paper page
- Tang, 2006, Regulatory T-cell physiology and application to treat autoimmunity, Immunol Rev, 212, 217, 10.1111/j.0105-2896.2006.00421.x · DOI · Paper page
- Friedmann-Morvinski, 2005, Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation, Blood, 105, 3087, 10.1182/blood-2004-09-3737 · DOI
- Pulè, 2005, A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells, Mol Ther, 12, 933, 10.1016/j.ymthe.2005.04.016 · DOI · Paper page
- Xu, 2007, Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta, J Immunol, 178, 6725, 10.4049/jimmunol.178.11.6725 · DOI · Paper page
- Zhou, 2010, Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu, J Immunol, 185, 2675, 10.4049/jimmunol.1000598 · DOI · Paper page
- Beavis, 2011, Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells, Proc Natl Acad Sci USA, 108, 16717, 10.1073/pnas.1112722108 · DOI
- Parish, 2009, Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation, Curr Protoc Immunol, Chapter 4, Unit4.9
- Becker, 2005, In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy, Gut, 54, 950, 10.1136/gut.2004.061283 · DOI · Paper page
Cited by
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
Therapeutic T cell engineering
Sadelain, M., Rivière, I., & Riddell, S. (2017) · Nature · doi:10.1038/nature22395 · Cited by 879
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Larson, R. C., & Maus, M. V. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00323-z · Cited by 852
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
MacDonald, K. G., Hoeppli, R. E., Huang, Q., Gillies, J., Luciani, D. S., Orban, P. C., Broady, R., & Levings, M. K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82771 · Cited by 494
Next-generation regulatory T cell therapy
Ferreira, L. M. R., Muller, Y. D., Bluestone, J. A., & Tang, Q. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0041-4 · Cited by 476
Metadata
- Authors
- Blat, D., Zigmond, E., Alteber, Z., Waks, T., & Eshhar, Z.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 22
- Issue
- 5
- Pages
- 1018-1028
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2067270731
- Cited by
- 246
- References
- 6
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 890 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.